Meta-analysis of Efficacy and Safety of Salmeterol and Fluticasone Propionate Aerosol in the Treatment of AECOPD
10.6039/j.issn.1001-0408.2015.21.26
- VernacularTitle:沙美特罗替卡松粉吸入剂治疗慢性阻塞性肺疾病急性加重期疗效和安全性的Meta分析
- Author:
Rui LI
;
Xin LIU
;
Laichun LU
;
Mingxia WANG
- Publication Type:Journal Article
- Keywords:
Salmeterol and fluticasone propionate aerosol;
COPD;
Acute exacerbation period;
Meta-analysis;
Efficacy;
Safety
- From:
China Pharmacy
2015;(21):2950-2952,2953
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To systematically review the efficacy and safety of salmeterol and fluticasone propionate aerosol in the treatment of AECOPD and provide evidence-based reference for the clinical treatment. METHODS:CJFD,Wanfang database, VIP,CBM,Cochrane Library,PubMed and EMBase were retrieved to collect the randomized controlled trial(RCT)of efficacy and safety of salmeterol and fluticasone propionate aerosol in the treatment of AECOPD. After information collection and quality evalua-tion,Meta-analysis was performed by using Rev Man 5.1 software. RESULTS:There were totally 17 RCTs,including 2 872 pa-tients. Results of Meta-analysis showed FEV1[SMD=0.47,95%CI(0.41,0.53),P<0.001],FEV1/FVC [SMD=1.08,95%CI(0.76, 1.39),P<0.001],FEV1 percentage of predicted value[SMD=0.83,95%CI(0.60,1.06),P<0.001] and incidence of adverse reac-tions [RR=1.38,95%CI(1.02,1.87),P=0.03] in test group were significantly higher than control group,with significant differenc-es. CONCLUSIONS:Salmeterol and fluticasone propionate aerosol has good efficacy in the treatment of AECOPD,can better im-prove patients’lung function and the safety needs to be improved. Due to the limit of research methodology,it remains to be fur-ther verified by large-sample and high-quality RCT.
